WHO Drug Information Vol. 14, No. 1, 2000
(2000; 81 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuGeneral Policy Issues
Ouvrir ce répertoire et afficher son contenuPersonal Perspectives
Ouvrir ce répertoire et afficher son contenuReports on Individual Drugs
Ouvrir ce répertoire et afficher son contenuCurrent Topics
Ouvrir ce répertoire et afficher son contenuVaccines and Biomedicines
Ouvrir ce répertoire et afficher son contenuGeneral Information
Fermer ce répertoireRegulatory and Safety Matters
Afficher le documentTroglitazone withdrawn
Afficher le documentCisapride and cardiac effects
Afficher le documentCisapride: changes to labelling
Afficher le documentCisapride: updated warning issued
Afficher le documentSt John's wort: recommendations for use
Afficher le documentNorthern hemisphere influenza vaccine
Afficher le documentNicotine replacement therapy
Afficher le documentAnorectic agents: suspension of marketing authorization
Afficher le documentInsulin cartridges: leakage risk
Afficher le documentZimox®: trade name duplication and risk of errors
Afficher le documentBenzbromarone and hepatitis
Afficher le documentNevirapine: severe cutaneous reactions
Afficher le documentFDA cannot regulate tobacco industry
Afficher le documentNew Internet website: information for consumers
Afficher le documentCyber warnings for drug sales via the Internet
Afficher le documentTriax®: a harmful product sold on the Internet
Afficher le documentIllegal products on the market
Afficher le documentEpoetin alfa: inappropriate practices compromise product sterility
Afficher le documentPropylene glycol and amprenavir
Afficher le documentTrastuzumab: pulmonary reactions
Ouvrir ce répertoire et afficher son contenuATC/DDD Classification
Ouvrir ce répertoire et afficher son contenuRecent Publications and Documents
Ouvrir ce répertoire et afficher son contenuInternational Nonproprietary Names for Pharmaceutical Substances (INN)
Afficher le documentSelected WHO Publications of Related Interest
 

Cyber warnings for drug sales via the Internet

United States of America - In recent weeks the Food and Drug Administration has issued letters via the Internet to operators of non USA-based internet sites that offer to sell on-line prescription medicines that may be illegal. The letters inform the operators about the laws governing prescription drug sales within the USA, with an explanation of the statutory provisions that govern interstate commerce of drugs and a warning that future shipments of the products may be automatically detained and subject to refusal of entry.

Reference: FDA Talk Paper, T00-8 (2000).

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013